Cerebral Stock
Cerebral, Inc. operates as a telemedicine mental health startup, providing both evidence-based therapeutic techniques and medication management.
Sign up for SecondMarket™ to view the market and buy or sell Cerebral Stock
Buy + SellCerebral Funding
Sign up to gain insights into Cerebral funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
Nov 22, 2021 | Series C | 298.83M | ||
Oct 19, 2021 | Series B | 126.40M | ||
Oct 29, 2020 | Series A | 636.99K | ||
Oct 29, 2020 | Series A | 404.36K | ||
Oct 29, 2020 | Series A | 5.00K | ||
Oct 29, 2020 | Series A | 27.55M | ||
Oct 29, 2020 | Series A | 875.00K | ||
Oct 29, 2020 | Series A | 5.11M | ||
Oct 29, 2020 | Series A | 2.50K | ||
Oct 29, 2020 | Series A | 659.47K |
See Cerebral Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Cerebral Stock Valuation + Share Prices
View real-time Tape D™ data on Cerebral stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedCerebral Management Team
CEO
David Mou
Founder
Kyle Robertson
Cerebral Major Investors
Access Industries
AirAngels
Artis Ventures
Gaingels Syndicate
Liquid 2 Ventures LP
Oak HC/FT Partners
Silver Lake Waterman
WestCap Group
Prysm Capital
SoftBank